Individuals Stopping Weight-Loss Injections Put On Weight Far More Rapidly Compared to Dieters

Fresh analysis reveals that people who come off blockbuster weight-loss injections like Mounjaro or Wegovy can put back on reduced body mass far faster than those who end traditional diet and exercise regimens.

Research printed in a major health publication points out that while obese people can lose substantial amounts of their total mass while on the medication, the weight returns at an average rate of 0.8 kg per month once they quit.

"People buying such treatments need to be aware of the danger of rapid rebound weight gain when the therapy is stopped," warns expert Dr. Susan Jebb.

This pace of regain suggests a reversion to pre-treatment weight in about a year and a half.

Analyzing Approaches

The analysis, which examined 37 of trials involving thousands of patients, contrasted the results of GLP-1 agonists with other pills.

The team note that people who shed pounds through diet and exercise typically have a less rapid creep back—approximately 0.1 kg a month—after stopping.

Understanding the Rapid Regain

Doctors believe the mode of action of the injections explains the amplified weight return.

These medications mimic a body's own chemical called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Long-term administration of the hormone concentrations several times higher than the body's typical production might result in the system to produce less of its own natural GLP-1, and may also reduce responsiveness to its effects," said Dr. Adam Collins, a dietetics researcher.

"Discontinuation of this medication leads to appetite is uncontrolled, making overeating far more likely."

A Lifelong Disease?

Health authorities suggest the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.

Many experts say that, due to the high risk of relapse, the treatment might need to be life-long.

This opinion is echoed by drug manufacturers, who note that the findings "emphasize the persistent character of excess weight," akin to managing conditions like diabetes.

User Experiences

Users who have come off the jabs report a intense return of cravings.

"I experienced a switch that goes on and you're instantly extremely hungry," said an individual.

This difficulty is compounded if patients have not developed sustainable dietary or behavioural modifications during therapy.

Significant Adoption

Recent estimates indicate that millions of people in the UK have tried these injections in the last 12 months, with interest continuing to grow.

• Use is more common among women than males.
• The 40s and 50s demographic shows the greatest level of interest.
• A large proportion obtain the drugs through private prescriptions rather than the NHS.

In conclusion, researchers caution that while these medications are powerful agents for shedding pounds, they are not a magic solution and long-term success hinges on ongoing lifestyle support.